TW270085B - - Google Patents

Info

Publication number
TW270085B
TW270085B TW083102311A TW83102311A TW270085B TW 270085 B TW270085 B TW 270085B TW 083102311 A TW083102311 A TW 083102311A TW 83102311 A TW83102311 A TW 83102311A TW 270085 B TW270085 B TW 270085B
Authority
TW
Taiwan
Prior art keywords
silicate
silicate polymer
function
polymer
regulates
Prior art date
Application number
TW083102311A
Other languages
English (en)
Chinese (zh)
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of TW270085B publication Critical patent/TW270085B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Silicon Compounds (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW083102311A 1993-03-19 1994-03-17 TW270085B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5085322A JP2588109B2 (ja) 1993-03-19 1993-03-19 鎮痛剤

Publications (1)

Publication Number Publication Date
TW270085B true TW270085B (enExample) 1996-02-11

Family

ID=13855390

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083102311A TW270085B (enExample) 1993-03-19 1994-03-17

Country Status (11)

Country Link
US (3) US5534509A (enExample)
EP (1) EP0621038B1 (enExample)
JP (1) JP2588109B2 (enExample)
KR (2) KR100268575B1 (enExample)
CN (1) CN1078469C (enExample)
AT (1) ATE173932T1 (enExample)
DE (1) DE69414904T2 (enExample)
DK (1) DK0621038T3 (enExample)
ES (1) ES2127302T3 (enExample)
SG (1) SG45236A1 (enExample)
TW (1) TW270085B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
EP1046397A3 (en) * 1999-04-15 2003-04-23 Nippon Zoki Pharmaceutical Co. Ltd. Novel bioactivating substance
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
KR100532915B1 (ko) * 2002-10-29 2005-12-02 삼성전자주식회사 단당류계 또는 올리고당류계 포로젠을 포함하는 다공성층간 절연막을 형성하기 위한 조성물
JP4145262B2 (ja) * 2004-03-23 2008-09-03 三洋電機株式会社 積層セラミック基板
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
US20100278935A1 (en) * 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
EP3305305B1 (en) 2007-10-15 2021-06-09 HS Pharmaceuticals, LLC Silicate containing compositions and methods of treatment
GB0805279D0 (en) * 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
EP2151466A1 (en) * 2008-08-01 2010-02-10 SiNatur GmbH Biologically active silicic acid
DE102010008982A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
DE102010008981A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
JP5937089B2 (ja) 2010-10-14 2016-06-22 日本臓器製薬株式会社 軟骨細胞におけるコラーゲン及びプロテオグリカン合成促進方法
CA2830654A1 (en) * 2011-03-31 2012-10-04 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
GB201402669D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Stabilised silicate compositions and their uses
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
CN105943566A (zh) * 2016-04-21 2016-09-21 叶卫斌 水溶性硅与中药材或食材提取物之复方制剂的制备方法
JP7510254B2 (ja) 2016-08-10 2024-07-03 ユナイテッド キングダム リサーチ アンド イノベーション ナノシリカ粒子を含む組成物および療法のためにｔリンパ球を活性化する方法におけるそれらの使用
CN110818902B (zh) * 2019-11-05 2021-11-16 塔里木大学 一种酰氧化聚硅酸化合物及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB697351A (en) * 1951-01-16 1953-09-23 Masuichi Takino Improved process for the manufacture of nerve sedatives
US3959566A (en) * 1974-10-21 1976-05-25 E. I. Du Pont De Nemours And Company Process for preparing polymeric surfaces to improve antistatic and soil resistant properties
US4036787A (en) * 1975-09-12 1977-07-19 Blount David H Process for the production of epoxy silicate compounds and polymers
US4039474A (en) * 1975-10-20 1977-08-02 Nalco Chemical Company Silica-alumina catalysts
US4056937A (en) * 1976-01-08 1977-11-08 Kyokado Engineering Co. Ltd. Method of consolidating soils
US4089883A (en) * 1976-07-09 1978-05-16 Blount David H Process for the production of organic hydroxy silicate compounds and their condensation products
US4104456A (en) * 1977-01-06 1978-08-01 Blount David H Process for the production of poly(allylhalide-allyl alcohol)
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5777697A (en) * 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS57183720A (en) * 1981-05-01 1982-11-12 Junji Mitani Health drug for fish farming
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS58121217A (ja) * 1982-01-13 1983-07-19 Takeo Kagitani 火傷薬
US4640361A (en) * 1985-12-13 1987-02-03 Halliburton Company Thermally responsive aqueous silicate mixtures and use thereof
JPS62145022A (ja) * 1985-12-18 1987-06-29 Sofuto Shirika Kk 食中毒症用薬剤
KR960009766B1 (ko) * 1986-09-10 1996-07-24 니혼 소오끼 세이야꾸 가부시기가이샤 생리 활성물질 측정법
JP2651674B2 (ja) * 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
US4863518A (en) * 1987-10-19 1989-09-05 Blount David H Production of polyol-alkali metal silicate glass emulsion
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
DE68909100T2 (de) * 1988-04-30 1994-01-13 Nippon Zoki Pharmaceutical Co Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon.
SE461156B (sv) * 1988-05-25 1990-01-15 Eka Nobel Ab Saett foer framstaellning av papper varvid formning och avvattning aeger rum i naervaro av en aluminiumfoerening, ett katjoniskt retentionsmedel och en polymer kiselsyra
JP2539665B2 (ja) * 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
EP0479218B1 (en) * 1990-10-01 1994-03-30 Suido Kiko Kabushiki Kaisha Flocculant for water treament and method for producing it
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
US5523295A (en) * 1994-07-06 1996-06-04 Brandeis University Method for treating and preventing alzheimer's disease

Also Published As

Publication number Publication date
DE69414904D1 (de) 1999-01-14
KR100268575B1 (ko) 2000-11-01
KR940021071A (ko) 1994-10-17
JPH06271471A (ja) 1994-09-27
DK0621038T3 (da) 1999-08-16
EP0621038B1 (en) 1998-12-02
ATE173932T1 (de) 1998-12-15
SG45236A1 (en) 1998-01-16
US5658896A (en) 1997-08-19
EP0621038A1 (en) 1994-10-26
ES2127302T3 (es) 1999-04-16
CN1101260A (zh) 1995-04-12
US5807951A (en) 1998-09-15
JP2588109B2 (ja) 1997-03-05
US5534509A (en) 1996-07-09
DE69414904T2 (de) 1999-05-12
CN1078469C (zh) 2002-01-30
KR100294580B1 (ko) 2001-07-03

Similar Documents

Publication Publication Date Title
TW270085B (enExample)
CA2107709A1 (en) Calcium Agent for Plants
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
IL109578A (en) Nor-bile acid derivatives processes for their preparation and the use of these compounds as medicaments
CS782686A2 (en) Method of benzimidazole derivatives production
NO972814D0 (no) Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav
EP0391002A3 (en) Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid
DE59405376D1 (de) Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
CA2176223A1 (en) Fenbendazole formulations
EG20408A (en) Process for formaldehyde content reduction in microcapsule formulations
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
DE69427949D1 (de) Acriflavine enthaltende Arzneimittel verwendbar zur Behandlung von Herpes und Zona
AU3202393A (en) Cyclic amp derivative-containing ointment
ATE179606T1 (de) Minocyclin enthaltende pellets
AU617573B2 (en) Sustained release pharmaceutical composition
BG102055A (en) Method for the manufacture of pest control preparations with sulphur as an active substance
CA2505487A1 (en) Levobupivacaine and its use as an anaesthetic in obstetrics